Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 2, 2008, Pages 193-201

  Montero, Elvira ^a   Abreu, Carmen ^b   Tonino, Paola ^a  

^a FACULTAD DE CIENCIAS   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Clinicopathological factors; Gastrointestinal carcinomas; Immunohistochemistry; p53; PCNA; VEGF

Indexed keywords

CYCLINE; PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER INVASION; CANCER PATIENT; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GASTRITIS; GASTROINTESTINAL CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; PRIORITY JOURNAL; STAINING; TUMOR CELL; TUMOR VOLUME;

AGED; CELL PROLIFERATION; FEMALE; GASTRITIS; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36849057578     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0270-5     Document Type: Article

References (60)

1. Buglioni S, D'Agnano I, Vasselli S, Perrone R, D'Angelo C, Brenna A, Benevolo M, Cosimelli M, Zupi G, Mottolese M (2001) p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy. Am J Clin Pathol 116:360-368
2. Capello F, Ribbene A, Campanella C, Czarnecka AM, Anzalone R, Bucchieri F, Palma A, Zummo G (2006) The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review. Eur J Histochem 50:25-34
3. Constantinou C, Bushell M, Jeffrey, Tilleray V, West M, Frost V, Hensold J, Clemens J (2003) p53-induced inhibition of protein synthesis is independent of apoptosis. Eur J Biochem 270:3122-3132
4. Cristi E, Perrone G, Toscano G, Verzì A, Nori S, Santini D, Tonini G, Vetrani A, Fabiano A, Rabitti C (2005) Tumour proliferation, angiogenesis, and ploidy status in human colon cancer. J Clin Pathol 58:1170-1174
5. Doussis-Anagnostopoulou I, Talks K, Turley H, Debnam P, Tan D, Mariatos G, Gorgoulis V, Kittas C, Gatter C (2002) Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease. J Pathol 97:677-683
6. Ellis LM, Takahashi Y, Liu W, Shaheen RM (2000) Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist 1:11-15
7. Fenoglio-Preiser C, Wang J, Stemmermann G, Noffsinger A (2003) TP53 and gastric carcinoma: a review. Hum Mutat 21:258-270
8. Ferrara N (1999) Role of vascular endothelial growth factor in regulation of angiogenesis. In: Teicher BA (ed) Antiangiogenic agents in cancer therapy. Humana Press, Totowa, New Jersey, pp 119-141
9. Ferrara N (2000) The role of vascular endothelial growth factor in angiogenesis. In: Rubanyi GM (ed) Angiogenesis in health and disease. Marcel Dekker, New York, Basel, pp 47-73
10. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581-611
11. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186
12. Folkman J, Merler E, Abernathy C, Williams G (1971) Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133:275-288
13. Fontanini G, Boldrini L, Vignati S, Chine S, Basolo F, Silvestri V, Lucchi M, Mussi A, Angeletti CA, Bevilacqua G (1998) Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma. Eur J Cancer 34:718-723
14. Fontanini G, Faviana P, Lucchi M, Boldrini L, Mussi A, Camacci T, Mariani MA, Angeletti CA, Basolo F, Pingitore R (2002) A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma. Br J Cancer 86:558-563
15. Fujiwaki R, Hata K, Iida K, Maede Y, Watanabe Y, Koike M, Miyazaki K (1999) Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer. Acta Obstet Gynecol Scand 78:728-734
16. Furihala M, Kurabayashl A, Matsumoto M, Sonobe H, Ohtsuki Y, Lerao N, Kuwahara M, Shuin T (2002) Frequent phosporylation at serine 392 in overexpressed p53 protein due to missense mutation in carcinoma of the urinary tract. J Pathol 197:82-88
17. Giatromanolaki A, Koukourakis M, Kakolyris S, Turley AH, O'Byrne K, Scott P, Pezzella F, Georgoulias V, Harris A, Gatter K (1998) Vascular endothelial growth factor, wild-type p53, angiogenesis in early operable non-small cell lung cancer. Clin Cancer Res 4:3017-3024
18. Guan Y-H, He Q, La Z (2006) Roles of p53 in carcinogenesis, diagnosis and treatment of hepatocellular carcinoma. J Cancer Mol 2:191-197
19. Gunsilius E, Tschmelitsch J, Eberwein M, Schwelberger H, Spizzo G, Kähler C, Stockhammer G, Lang A, Petzer A, Gastl G (2002) In vivo release of vascular endothelial growth factor from colorectal carcinomas. Oncology 62:313-317
20. Hasan J, Byersm R, Jayson GC (2002) Intratumoral microvessel density in human solid tumors. Cancer Res 86:1566-1577
21. Haupt Y, Robles A, Prives C, Rotter V (2002) Deconstruction of p53 functions and regulation. Oncogene 21:8223-8231
22. Kaklamanis L, Savage S, Whitehouse R, Doussis-Anagnostopoulou I, Biddolph S, Tsiotos P, Mortensen N, Gatter KC, Harris AL (1998) Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. Br J Cancer 77:1864-1869
23. Kondo Y, Arii S, Furutani M, Isigami S, Mori A, Onodera H, Chiba T, Imamura M (2000) Implication of vascular endothelial growth factor and p53 status for angiogenesis in non-invasive colorectal carcinoma. Cancer 88:1820-1827
24. Kontogianni K, Demonakou M, Kavantzas N, Lazaris ACh, Lariou K, Vourlakou C, Davaris P (2003) Prognostic predictors of gastrointestinal stromal tumors: a multi-institutional analysis of 102 patients with definition of a prognostic index. Eur J Surg Oncol 29:548-556
25. Kushlinskii NE, Orinovskii MB, Gurevich LE, Kazantseva IA, Talaeva ShZh, Shirokii VP, Ermilova VD, Dvorova EK, Ozherelev AS (2004) Expression of biomolecular markers (Ki-67, PCNA, Bcl-2, BAX, BclX, VEGF) in breast tumors. Bull Exp Biol Med 137:182-185
26. La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C (2003) Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features. Hum Pathol 34:18-27
27. Lanz C, Süsse S, Wies Müller L (2002) p53 and recombination intermediates: role of tetramerization at DNA junctions in complex formation and exonucleotic degradation. Oncogene 21:2130-2140
28. Lappi-Blanco E, Soini Y, Kinnula V, Pääkkö P (2002) VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia. J Pathol 196:220-227
29. Lim J, Kang S, Llee M, Pal H, Yoon H, Lee J, Hong S, Lim C (2003) Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32:552-561
30. Linden M, Torres F, Kubus J, Zarbo R (1992) Clinical application of morphologic and immunocytochemical assessments of cell proliferation. Am J Clin Pathol 97:S4-S13
31. Maeda K, Chung Y-S, Takatsuka S, Onoda N, Ogawa M, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y, Sowa M (1995) Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 72:319-323
32. Maeda K, Kang S-M, Onoda N, Ogawa M, Sawada T, Nakata B, Kato Y, Chung Y-S, Sowa M (1998a) Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer. Oncology 55:594-599
33. Maeda T, Matsumura S, Hiranuma H (1998b) Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumor progression and p53 status. J Clin Pathol 51:771-775
34. Maeda K, Kang S-M, Onoda N, Ogawa M, Sawada T, Kato Y, Chung Y-S (1999) Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. Am Cancer Soc 86:566-571
35. Maehara Y, Tomoda M, Hasuda S, Kabashima A, Tokunaga E, Kakeji Y, Sugimachi K (1999) Prognostic value of p53 protein expression for patients with gastric cancer-a multivariate analysis. Br J Cancer 79:1255-1261
36. Maehara Y, Kabashima A, Koga T, Tokunaga E, Takeuchi H, Kakeji Y, Sugimachi K (2000) Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 128:408-416
37. Maehara Y, Kakeji Y, Oda S, Baba H, Sugimachi K (2001) Tumor growth patterns and biological characteristics of early gastric carcinoma. Oncology 61:102-112
38. Marine J-C, Francoz S, Maetens M, Wahl G, Toledo F, Lozano G (2006) Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 13:927-34
39. WAF1, KI-67 expression patterns in gastric cancer. J Cell Physiol 210:183-191
40. McLeod HL, Murray GI (1999) Tumour markers of prognosis in colorectal cancer. Br J Cancer 79:191-203
41. Medri L, Volpi A, Nanni O, Vecci AM, Mangia A, Schittulli F, Padovani F, Giunchi DC, Zito A, Amadori D, Paradiso A, Silvestrini R (2003) Prognostic relevance of mitotic activity in patients with node-negative breast cancer. Mod Pathol 16:1067-1075
42. Nayak B, Das G (2002) Stabilization of p53 and transactivation of its target genes in response to replication blockade. Oncogene 21:7226-7229
43. Niu Q, Tang ZY, Ma ZC, Qin LX, Zhang LH (2000) Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol 6:565-568
44. Okuyama T, Maehara Y, Kabashima A, Takahashi I, Kakeji Y, Sugimachi K (2002) Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma. Oncology 63:353-361
45. Qiu L-L, Hua P-Y, Ye LL, Wang YC, Qiu T, Bao HZ, Wang L (2007) The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China. Cancer Det Prev 31:45-49
46. Reinmuth N, Parikh A, Ahmad SA, Liu W, Stoeltzing O, Takeda A, Akagi M, Ellis LM (2003) Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech 60:199-207
47. Rosa AR, Schirmer CC, Gurski RR, Meurer L, Edelweiss MI, Kruel CD (2003) Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus. Dis Esophagus 16:112-118
48. Saeki H, Ohno S, Miyazaki M, Araki K, Egashira A, Kawaguchi H, Watanabe K, Morita M, Sugimachi K (2002) p53 protein accumulation in multiple oesophageal squamous cell carcinoma: relationship to risk factors. Oncology 62:175-179
49. Saito H, Tujitani S, Ikegichu M, Maeta M, Kaibara N (1999) Neoangiogenesis and relationship to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma. Oncology 57:164-172
50. Sangrajrang S, Arpornwirat W, Cheirsilpa A, Thisuphakorn P, Kalalak A, Sornprom A, Soussi R (2003) Serum p53 antibodies in correlation to other biological parameters of breast cancer. Cancer Det Prev 27:182-186
51. Scoazec J-Y (2000) Tumor angiogenesis: a pathologist's point of view. Elect J Oncol 2:23-32
52. Smith DR, Ji C-Y, Goh H-S (1996) Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 74:216-223
53. Sumiyoshi Y, Yamashita Y, Maekawa T, Sakai N, Shirakusa T, Kikuchi M (2000) Expression of CD44, vascular endothelial growth factor, and proliferating cell nuclear antigen in severe venous invasional colorectal cancer and its relationship to liver metastasis. Surg Today 30:323-327
54. Takahashi Y, Bucana CD, Cleary KR, Ellis LM (1998) p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 79:34-38
55. Takahashi R, Tanaka S, Kitadai Y, Sumii M, Yoshihara M, Haruma K, Chayama K (2003) Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology 64:266-274
56. Uehara M, Sano K, Ikeda H, Sekine J, Irie A, Yokota T, Tobita T, OHba S, Inokuchi T (2004) Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma. Oral Oncol 40:321-325
57. van Diest PJ, Brugal G, Baak JP (1998) Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol 51:716-724
58. van Houten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, Leemans R, van der Waal I, Snow GB, Brakenhoff RH (2002) Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 198:476-486
59. Vesselle H, Schmidt R, Pugsley JM, Li M, Kohlmyer SG, Vallires E, Wood DE (2000) Lung cancer proliferation correlates with (F-18) fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6:3837-3844
60. Woods DB, Vousden KH (2001) Regulation of p53 function. Exp Cell Res 264:56-66